Related Experiment Video
Updated: Jul 9, 2026

08:04
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Is flow cytometry accurate enough to screen platelet autoantibodies?
Nathalie Hézard1, Gérard Simon, Catherine Macé
1Laboratoire d'Hématologie, CHU Robert Debré, Reims, France.
Transfusion
|December 11, 2007
Summary
Flow cytometry for detecting platelet-associated immunoglobulin G (PAIgG) can accurately screen immune thrombocytopenic purpura (ITP) patients, reducing the need for specialized MAIPA testing in 42% of cases. This method aids in efficient ITP diagnosis and follow-up.
Area of Science:
- Hematology
- Immunology
- Diagnostic Medicine
Background:
- Immune thrombocytopenic purpura (ITP) diagnosis is often a diagnosis of exclusion.
- Platelet (PLT) antibody assessment aids ITP diagnosis and follow-up.
- Specialized assays like MAIPA detect PLT antibodies; flow cytometry for PAIgG is a newer method.
Purpose of the Study:
- To evaluate the utility of flow cytometry for accurately screening patients requiring further MAIPA testing for ITP.
- To assess the accuracy of flow cytometry in detecting platelet antibodies compared to the MAIPA assay.
Main Methods:
- PAIgG, PAIgM, and PAIgA were measured in 107 ITP patients and 147 healthy controls using flow cytometry.
- MAIPA testing was performed on all patients.
- Receiver operating characteristics (ROC) curve analysis compared flow cytometry accuracy against MAIPA.
Main Results:
- MAIPA assay identified PLT-specific IgG in 25% of patients.
- Flow cytometry with a mean fluorescence intensity (MFI) cutoff of 0.2 showed no false-negative PAIgG results.
- Using this cutoff, 57% of patients had positive PAIgG, rendering MAIPA unnecessary in 42% of cases.
Conclusions:
- Flow cytometry for PAIgG assessment effectively determines the need for subsequent MAIPA testing.
- MAIPA testing was found to be unnecessary in 42% of the studied patients.
- PAIgM determination alongside PAIgG may offer additional value in ITP investigations.
